Neuromyelitis Optica, Part 2: Pathogenesis
Now that we’ve seen how researchers came to the conclusion that NMO differs from MS, let’s take a closer look at the current understanding of its pathogenesis
About three-quarters of NMO patients have the aquaporin-4 antibody, a number that has been steadily...
Clinical Research, Drug Development, Laboratory Research, People